Skip to main content

Table 1 Composition of the adjuvanted influenza vaccine formulations

From: Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Formulation α -tocopherol (mg) MPL (μg)
AS03C 2.97 0
AS03C-MPL25 2.97 25
AS03C-MPL50 2.97 50
AS03B 5.93 0
AS03B-MPL25 5.93 25
AS03B-MPL50 5.93 50
AS03A 11.86 0
AS03A-MPL25 11.86 25
  1. All formulations of the vaccine contained AS03, which is a squalene and α-tocopherol oil-in-water emulsion-based Adjuvant System. MPL is 3-O-desacyl-4’- monophosphoryl lipid A.